We are live on
!
Find out more
M
Mirova Portfolio holdings
AUM
$2.46B
1-Year Est. Return
11.42%
This Fund
S&P 500
This Quarter
Est. Return
-3.49%
1 Year Est. Return
+11.42%
3 Year Est. Return
+32%
5 Year Est. Return
+23.08%
10 Year Est. Return
–
AUM
$556M
AUM Growth
-$23.6M
(-4.1%)
Cap. Flow
+$4.75M
Cap. Flow
% of AUM
0.85%
Top 10 Holdings %
Top 10 Hldgs %
50.58%
Holding
134
New
5
Increased
44
Reduced
35
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sunrun
RUN
|
+$1.88M |
| 2 |
Zurn Elkay Water Solutions
ZWS
|
+$1.75M |
| 3 |
EnerSys
ENS
|
+$1.73M |
| 4 |
Cisco
CSCO
|
+$1.28M |
| 5 |
PTC
PTC
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$5.64M |
| 2 |
Trane Technologies
TT
|
+$2.11M |
| 3 |
Colgate-Palmolive
CL
|
+$1.89M |
| 4 |
Accenture
ACN
|
+$1.58M |
| 5 |
Ecolab
ECL
|
+$1.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Healthcare | 23.47% |
| 3 | Industrials | 14.08% |
| 4 | Materials | 9.95% |
| 5 | Consumer Discretionary | 7.11% |
Similar funds
BW
SCM
GWM
TW
JC
SG
RL
QT
Mirova's Q1 2025 Portfolio in Review
As of Q1 2025, Mirova held 134 positions worth $556M, down 4.1% from $580M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.7%. Mirova opened 5 new positions and made no exits, leaving the 134-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.
- Mirova's largest Q1 2025 buy was Zurn Elkay Water Solutions: 48,509 shares worth $1.6M.
- Mirova added most to Sunrun in Q1 2025, an estimated $1.88M increase.
- Mirova's biggest Q1 2025 reduction was Thermo Fisher Scientific, cutting an estimated $5.64M.
- Mirova's ten largest holdings make up 51% of its $556M portfolio in Q1 2025.
- Mirova opened 5 new positions and closed 0 in Q1 2025.
- Mirova's portfolio value fell 4.1% quarter-over-quarter to $556M.
Based on Mirova's 13F filing for Q1 2025, filed 14 May 2025.